SynAct Pharma AB
STO:SYNACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SynAct Pharma AB
STO:SYNACT
|
SE |
|
Banca Generali SpA
MIL:BGN
|
IT |
|
B
|
Blue Cloud Softech Solutions Ltd
BSE:539607
|
IN |
|
Doximity Inc
NYSE:DOCS
|
US |
|
A
|
Adventa Bhd
KLSE:ADVENTA
|
MY |
|
American Bio Medica Corp
OTC:ABMC
|
US |
|
China E-Wallet Payment Group Ltd
HKEX:802
|
MY |
|
P
|
President Bakery PCL
SET:PB
|
TH |
|
BTC Digital Ltd
NASDAQ:BTCT
|
CN |
|
H
|
Hyundai Hyms Co Ltd
KOSDAQ:460930
|
KR |
Wall St Price Targets
SYNACT Price Targets Summary
SynAct Pharma AB
According to Wall Street analysts, the average 1-year price target for SYNACT is 29.02 SEK with a low forecast of 28.73 SEK and a high forecast of 29.87 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SYNACT's stock price target?
Price Target
29.02
SEK
According to Wall Street analysts, the average 1-year price target for SYNACT is 29.02 SEK with a low forecast of 28.73 SEK and a high forecast of 29.87 SEK.